BCAL vs WST · P/E 11, rev $226.0M vs P/E 35, rev $1.72B
Southern California Bancorp Common Stock (BCAL) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Southern California Bancorp Common Stock (BCAL) is a banks - regional company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported BCAL revenue for 2025-12-31 was $226.0M. Net income was $63.1M. Revenue was up 25.7% from 2024-12-31 to 2025-12-31. BCAL currently screens at market cap $628.2M and trailing P/E 10.7.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
BCAL currently screens at market cap $628.2M and trailing P/E 10.7. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the BCAL and WST stock pages for the full models.
Not investment advice.